Bio X Cell - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Editorial infographic showing an oil refinery at sunset with market-style chart lines and key ExxonMobil Q3 2026 indicators, including a $4.5 billion refining-margin uplift, a $1.3 billion upstream hit from lower liquids prices, a $2.5 billion timing effect, and an October 30, 2026 results date.

ExxonMobil signals $4.5bn refining earnings boost as oil-price pressure hits upstream

Anthropic brings frontier AI to power grids and water utilities in major cybersecurity initiative

Rubrik (NYSE: RBRK) expands AI cybersecurity alliance as Code Guardian enters enterprise delivery push

GlobalFoundries wins $2bn TSMC AI packaging agreement with production set for 2028

Windjammer Capital Investors Acquires Bio X Cell, Expanding Presence in Biotech Sector

Read More

Pharma Industry News

Windjammer Capital acquires monoclonal antibodies producer Bio X Cell

Windjammer Capital Investors (“Windjammer”), a notable private equity investment firm, has announced its acquisition of Bio X Cell,…

byPallavi Madhiraju

December 13, 2023

web analytics